دانلود کتاب پاتوژنز، تشخیص و درمان اختلالات عصبی عضلانی اکتسابی

This second edition of the book was finalised during the Covid-19 pandemia, and I thank all contributors that prepared their chapters in such difficult times.

In Europe. the first severe acute respiratory syndrome coronavirus (SARS-CoV-2) cases were documented in January 2020, and the first affected case was found in Codogno Hospital, Milan, and the first deceased case occurred in February 2020 in Schiavonia Hospital, Padova, Italy.

There were almost two years of ongoing cycles of imposing and easing restric­tions to suppress the epidemia since most European countries experienced its first large wave in March 2020–July 2020, which stretched to the second wave in autumn 2020.

With the appearance of alpha, beta, delta, omicron variants of coronavirus, there were several diffuse outbreaks that further stretched the fragmented resources of the National Health Systems.

The category of patients afflicted by neuromuscular disease covers a wide range of different diagnoses with widely varying levels of disability, even in patients with the same diagnosis. It is difficult therefore to make specific recommendations for Covid-19 that apply generally.

The following are recommendations that apply to acquired neuromuscular disor­ders. The recommendations are designed primarily for patients, carers, and non-specialist medical providers. They are also intended to inform neuromuscular specialists particularly regarding basic service requirements.